FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32111000001108: Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1848861000001116 Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1848871000001114 Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Is a Product containing precisely atenolol 50 milligram and chlortalidone 12.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Has active ingredient Thiazide diuretic false Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Has active ingredient Chlortalidone false Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Has active ingredient Atenolol false Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Has specific active ingredient Atenolol true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Has specific active ingredient Chlortalidone true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Is pack of False Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has AMP True Co-tenidone 50mg/12.5mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start